Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission. 2022 was a milestone year for th...
Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article by James Hallifax was originally published on Microdose and appears here with permission. 2022 was a milestone year for th...
Top-line phase 2a trial results of experimental psychedelic tryptamine showed a 57% reduction in major depressive disorder symptoms 3 months after a single dose when combined with supportive therapy.
DMT — the most potent psychedelic known to man — treats people with severe depression after a single dose, a cutting-edge clinical trial suggests. Up to six in ten who received a single dose of DMT intravenously before therapy were declared...
First placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression demonstrates rapid and durable response Primary endpoint met with a statistically significant
Up to six in ten who received a single dose of DMT intravenously before therapy were declared depression-free three months later, in a clinical trial by Canada-based Small Pharma.